Examining the Sudan virus epidemic in Uganda via the use of a mobile laboratory - Report - MDSpire

Examining the Sudan virus epidemic in Uganda via the use of a mobile laboratory

  • By

  • Godfrey Pimundu

  • Tonny Muyigi

  • Eunice Jennifer Nambozo

  • Christopher Okiira

  • Benedict Kanamwanji

  • Rebecca Nalwanga

  • Joseph Sekate

  • Raymond Mugabe

  • Juliet Naiga

  • Isaac Sewanyana

  • Julius Lutwama

  • Stephen Balinandi

  • Pontiano Kaleebu

  • Jane Ruth Aceng

  • Diana Atwiine

  • Henry Mwebesa

  • Henry Kyobe Bosa

  • Atek Kagirita

  • Charles Olaro

  • Andrew Nsawotebba

  • Emmanuel Achol

  • Hakim Lagu

  • Eric Nzeyimana

  • Juergen May

  • Florian Gehre

  • Muna Affara

  • Susan Nabadda

  • January 16, 2026

  • 0 min

Share

Clinical Report: Examining the Sudan virus epidemic in Uganda via mobile lab

Overview

Expand on the specific methods used to reduce turnaround times and their direct impact on outbreak response.

Background

Ebola disease, caused by viruses in the Filoviridae family, poses a severe health threat, particularly in Africa. The Sudan virus has been responsible for multiple outbreaks in Uganda, highlighting the need for effective diagnostic and containment strategies. The recent outbreak in 2022 prompted the use of a mobile laboratory to address logistical challenges in testing and response.

Data Highlights

No numerical data provided in the source material.

Key Findings

  • The mobile laboratory was deployed on September 28, 2022, one week after the outbreak declaration.
  • It was positioned at the Mubende Regional Referral Hospital, adjacent to the Ebola Treatment Unit.
  • By the time of deployment, 26 cases had been confirmed by the Uganda Virus Research Institute.
  • The mobile lab aimed to reduce turnaround time for laboratory diagnostics, facilitating quicker containment efforts.
  • The initiative provided insights into the clinical virology of Sudan virus disease through extensive testing.

Clinical Implications

The use of mobile laboratories can significantly enhance outbreak response capabilities in remote areas, improving diagnostic efficiency and patient management. Healthcare providers should consider integrating mobile testing solutions in future outbreak preparedness plans.

Conclusion

The deployment of a mobile laboratory during the Sudan virus outbreak in Uganda exemplifies an effective strategy for improving diagnostic capabilities and outbreak management. Continued evaluation of such initiatives is essential for future public health responses.

References

  1. WHO, WHO, 2025 -- Sudan virus disease – Uganda
  2. Open Forum Infectious Diseases, 2021 -- Assessment of Portable Molecular Differential Testing in the Democratic Republic of Congo and Nigeria
  3. The Journal of Infectious Diseases, 2021 -- Endemic Rift Valley Fever in Southwestern Uganda Linked to Evolving Lineage C Viral Strains
  4. The Journal of Infectious Diseases, 2014 -- Investigating Infectious Etiologies of Fever of Unknown Origin: A Retrospective Laboratory Study of Suspected Ebola Virus Cases in Guinea, 2014
  5. The Journal of Infectious Diseases — Evaluation of Diagnostic Accuracy and Dynamics of Hepatitis E Viral RNA and IgM Antibody Positivity During a Genotype 1 Outbreak in South Sudan
  6. Sudan virus disease – Uganda
  7. Diagnostic testing for Ebola and Marburg virus diseases: interim guidance, 20 December 2024
  8. WHO/BS/2025.2494

Original Source(s)

Related Content